IGF2BP2 and acute myeloid leukemia: Further study of the mechanism revealed that IGF2BP2 could regulate glycolytic level by stabilizing the expression of DANCR and mediate miR-4701-5p/PKM pathway, thereby affecting the progression of FLT3-ITD + AML.